Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Drugs for Preventing Malaria in Pregnant Women in Endemic Areas: Any Drug Regimen versus Placebo or No Treatment

About this resource:

Systematic review

Source: The Cochrane Collaborative

Last Reviewed: October 2014

Workgroups: Global Health Workgroup

In this Cochrane systematic review, the Cochrane Collaborative found that giving women in their 1st or 2nd pregnancy antimalarial drugs can prevent moderate to severe anemia and prevent malaria parasites in the blood. The review included trials that evaluated 6 different antimalarials against placebo or no intervention. Researchers also found that when pregnant women take antimalarial drugs, their babies have increased average birth weight and are less likely to have a low birth weight.

Read more about this resource

Suggested Citation

1.

Radeva‐Petrova, D., Kayentao, K., ter Kuile, F. O., Sinclair, D., & Garner, P. (2014). Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment. Cochrane Database of Systematic Reviews, 2014 (10). DOI: 10.1002/14651858.CD000169.pub3.